[Eosinophil-induced lung injury].
Iwamoto
I
I
Second Department of Internal Medicine, Chiba University School of Medicine.
D000818:Animals; D001192:Arylsulfatases / Q000378:metabolism; D001249:Asthma / Q000209:etiology* / Q000473:pathology; D001798:Blood Proteins / Q000378:metabolism; D047091:Eosinophil Granule Proteins; D047209:Eosinophil Peroxidase; D047208:Eosinophil-Derived Neurotoxin; D004804:Eosinophils / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation; D009498:Neurotoxins / Q000378:metabolism; D010544:Peroxidases / Q000378:metabolism; D010739:Phospholipase D / Q000378:metabolism; D010972:Platelet Activating Factor / Q000502:physiology; D011657:Pulmonary Eosinophilia / Q000209:etiology* / Q000473:pathology; D012260:Ribonucleases; D013189:SRS-A / Q000502:physiology
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D009498:Neurotoxins; D010972:Platelet Activating Factor; D013189:SRS-A; D047209:Eosinophil Peroxidase; D010544:Peroxidases; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases; D010739:Phospholipase D; D001192:Arylsulfatases